Physical Plant Design and Engineering Controls and the Prevention of Nosocomial Infections and Antibiotic Resistant Organism Colonization Events - A Proposal for a Prospective Controlled Trial
Sponsor study identifier
interventional
1,514
1 country
1
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
February 2010
Actual (reported)Study Completion
February 2010
Actual (reported)With the construction of a new medical teaching ward with features designed to reduce hospital-acquired infections, we hypothesized that the design of the new ward was the major factor that contributed to the improved outcomes and designed a prospective, controlled study to examine this hypothesis.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2010
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
November 21, 2007
Actual (reported)November 26, 2007
Actual (reported)February 2010
Actual (reported)February 2010
Actual (reported)October 23, 2018
Actual (reported)Incidence Density of Hospital-acquired Infection With Clostridium Difficile (CDI), and Hospital-acquired Infection or Colonization With Vancomycin-resistant Enterococcus (VRE), or Methicillin-resistant Staphylococcus Aureus (MRSA).
participants were followed for the duration of hospital stay, an average of 10 days
Number of MRSA, VRE and CDI Occurring in Single-bed Rooms vs. Multiple Bed Rooms AND Occurring in Outbreaks Related to the Primary Case
in-hospital
Admission to a novel hospital ward (e.g. abundance of sinks, predominance (80%) of private rooms, absence of shared bathrooms, absence of curtains)
Hospital admission to a ward with traditional design features (eg. lack of sinks, predominance of 4-bed rooms \[80%\], shared bathrooms, curtains present)
Hospital admission to a ward with novel infection control design features (e.g., abundance of sinks, predominance (80%) of private rooms, absence of shared bathrooms, absence of curtains)
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Foothills Hospital
Calgary, Alberta, T2N 2T9, Canada
Chronic overcapacity issues impacted the ability to truly randomize which may have introduced a selection bias,there was an unanticipated conversion of single rooms to multi-bed rooms on the novel ward, limited generalizability outside GIM patients
John M Conly, MD
University of Calgary
William A Ghali, MD
University of Calgary
Manuel Mah, MD
Calgary Health Region
Donna Holton, MD
Calgary Health Region
1,514 participants (actual enrollment reported by the registry).
First Submitted
November 21, 2007
First Posted
November 26, 2007
Study Start
June 2007
Date type not reportedThis date has not been verified as actual or estimated.
Impact of Antibiotic Treatment on Outcome in Patients With Ventilator-Associated Tracheobronchitis
Contact the study team to confirm eligibility.
Elizabeth A Henderson, PhD
University of Calgary
Peter Faris, PhD
University of Calgary
Jean Wallace, PhD
University of Calgary
Primary Completion
February 2010
Actual (reported)Study Completion
February 2010
Actual (reported)Last Updated
October 23, 2018
Results First Posted
October 23, 2018
Record last verified: 2018-10
Published: J Ellison, D Southern, D Holton, et al. Hospital ward design and prevention of hospital-acquired infections: A prospective clinical trial. Can J Infect Dis Med Microbiol 2014;25(5):265-270. Data was coded and entered into a computer for analysis and was non-nominal to protect the privacy of the information. Since the data were bed-specific, we will not be sharing the de-identified data.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: